Join
Live feed
·
PRReleasevia Quantisnow
Amicus Therapeutics Inc. logo

Amicus Therapeutics Announces FDA Approval and Launch of New Treatment for Pompe Disease

ByQuantisnow·Wall Street's wire, on your screen.
FOLD· Amicus Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FOLD (Amicus Therapeutics Inc.) and more on Quantisnow.